Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA.
Department of Biostatistics, University of Alabama, Birmingham, AL, USA.
Am J Med Sci. 2022 Oct;364(4):433-443. doi: 10.1016/j.amjms.2022.04.024. Epub 2022 Apr 29.
Emerging evidence supports the superiority of balanced crystalloids such as Lactated Ringer's (LR) compared to normal saline but concerns for the development of hyperkalemia have limited its use. Although LR inherently contains potassium, there exists a paucity of evidence to suggest that LR could potentiate hyperkalemia. To address this, we evaluated the effect of LR on serum potassium in patients with reduced kidney function who are at risk of developing hyperkalemia.
We conducted a single-center, retrospective cohort-based observational clinical study that included 293 clinical encounters who were hospitalized with an estimated glomerular filtration rate (eGFR) of < 30 ml/min/1.73m, at the time of hospital admission. Subjects must have received a minimum of 500 ml of LR continuously during the admission. Only those with a minimum of one lab report within 24 hours prior to-, and post-LR administration that reported serum measurements of potassium, glucose, and bicarbonate levels were included. Other potential risk factors for developing hyperkalemia including medication, tube feeds, potassium supplements, and red blood cell transfusion during or within 24 hours after LR administration were recorded.
Serum potassium prior to LR use was highly correlated and predictive of the serum potassium after LR use [P < 0.0001; Odds Ratio 6.77 (3.73 - 12.28)]. Sixteen encounters (5%) developed de-novo hyperkalemia following LR use. No significant positive correlation between the amount of LR administered and the development of hyperkalemia was found.
LR use was not independently associated with the development of hyperkalemia in patients with reduced kidney function.
新出现的证据支持平衡晶体液(如乳酸林格氏液)优于生理盐水,但人们担心会发生高钾血症,这限制了其使用。尽管乳酸林格氏液本身含有钾,但目前几乎没有证据表明乳酸林格氏液会增强高钾血症。为了解决这个问题,我们评估了在肾功能降低且有发生高钾血症风险的患者中,LR 对血清钾的影响。
我们进行了一项单中心、基于回顾性队列的观察性临床研究,纳入了 293 例住院患者,入院时估计肾小球滤过率(eGFR)<30ml/min/1.73m。患者在住院期间必须连续输注至少 500ml 的 LR。仅纳入那些在输注 LR 前后 24 小时内至少有一次实验室报告,且报告了血清钾、葡萄糖和碳酸氢盐水平测量值的患者。在输注 LR 期间或之后 24 小时内,记录了其他可能导致高钾血症的潜在危险因素,包括药物、管饲、钾补充剂和红细胞输血。
LR 使用前的血清钾与 LR 使用后的血清钾高度相关且具有预测性[P<0.0001;比值比 6.77(3.73-12.28)]。16 例(5%)在使用 LR 后出现新发高钾血症。未发现输注 LR 的量与高钾血症的发生之间存在显著正相关。
在肾功能降低的患者中,LR 的使用与高钾血症的发生无关。